Date
2020-
0506-
XX02
Time:
1800 1900- 1930 2030 UTC
1100 1200- 1230 1330 PDT
Zoom Meeting Details
Topic: SNOMED Editorial Advisory Group Conference Call
Time: Jun 2, 2020 12:00 PM Pacific Time (US and Canada)
Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/j/97507109544?pwd=bFVCZmhYZ1I2S1JIK3U1b2VBWnBEUT09
Password: 614316
Meeting ID: 975 0710 9544
Password: 614316
International numbers available: https://snomed.zoom.us/u/daDj0O3t9
Or Skype for Business (Lync):
https://snomed.zoom.us/skype/97507109544
Attendees
Chair:
AG Members
Invitees:
Apologies:
Meeting Files:
Objectives
- Obtain consensus on agenda items
Discussion items
Item | Description | Owner | Notes | Action | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Call to order and role call | Start recording! |
| |||||||||||||||
2 | Conflicts of interest and agenda review | No conflicts noted | SCALE TYPE editorial content | Based on discussion at the April 29 2020 conference call, the following is proposed to be added to the SNOMED CT Editorial guide:
|
| Antibody vs. Immunoglobulin | Farzaneh Ashrafi | |||||||||||
3 | Antibody vs. Immunoglobulin | Farzaneh Ashrafi | Establishing definitions for terms representing Antibody and Immunoglobulin Discussion: While most people think of Immunoglobulins and antibodies as the same, there are substantive differences between them. General agreement that Immunoglobulins are a supertype of antibodies. Antibodies are conceived as circulating structures but there are non-circulating immunoglobulins as well. While there are clear distinctions at a granular level, these two notions should not be disjoint. What we need in SNOMED CT is a clinically useful representation of these two concepts. The issue is how to properly represent Antibody (function) and immunoglobulin (structure). We need to make sure that whatever we choose, there must not be variability in the use of these to model other concepts. The vast majority of the time users will not make a distinction. Is there a benefit in having a defined distinction between immunoglobulin and antibody other than stating one is a subtype of the other? Is antibody a Role? Is a gamma globulin the same as immunoglobulin? Additional comments will be added to the JIRA ticket:
|
| ||||||||||||||
4 | Report from Concept inactivation workgroup | Paul Amos | The presentations will focus on 3 aspects:
Discussion: | |||||||||||||||
5 | ECE update | Bruce Goldberg |
Discussion: Initial testing of the impact of inactivation of 362977000 |Sequela (disorder)| and replacement with 64572001 |Disease (disorder)| in concepts that had it assigned as the IS A parent results in a more complete set of subtypes classifying under 302049001 |Sequelae of disorders (disorder)| and 312087002 |Disorder following clinical procedure (disorder)|. The availability of ECL was purported to be a more effective mechanism in identifying concepts that would be considered sequela or late effects than the manual assignment of a intermediate primitive concept. Bruce Goldberg was asked to do more evaluation of the results of the inactivation of 362977000 |Sequela (disorder)|. If no issues remain, this concept will be inactivated in the Jan 2021 release. | |||||||||||||||
6 | Report from Concept inactivation workgroup | Paul Amos | Next meeting | EAG | Doodle poll to be sent out for additional meeting in June Discussion: |